Mubasher Ahmad Sheikh

Permira Advisers LLP (Permira Advisers) is a private equity subsidiary of Permira Holdings Ltd founded in 1985 by Peter M. Smitham. The firm is headquartered in London, United Kingdom with additional offices in the United States and Asia.

Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway.

Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom.

Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU.

Althea Group Ltd. operates as a group of healthcare services. Its services include plan and deign, procure and finance, install and commission, management, maintain and upgrade, and refurbishment. The company was founded in 2014 and is headquartered in Theale, the United Kingdom.

Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom.

Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom.

QS Pharma LLC provides contract research services for pharmaceutical and biopharmaceutical companies. It offers NCE screening, identification, preformulation characterization, preclinical and toxicology, formulation development, clinical trial materials, potency manufacturing, analytical and commercial manufacture services. The company was founded in 2002 and is headquartered in Boothwyn, PA.